Lymphocyte aggregation in response to adrenergic stimulation.

Abstract:

:A nonanemic chronic lymphocytic leukemia patient with nearly 500,000 lymphocytes/microL underwent leukapheresis when she presented with CNS symptoms and retinal vascular engorgement. Respiratory distress developed during the cell separator run, which led us to ask whether the procedure could have changed the adhesive properties of her cells. C5a desarginine, N-f-Met-Leu-Phe, adenosine diphosphate, and collagen all failed to aggregate her lymphocytes in vitro, but arachidonic acid, excess free calcium, and 4 mumol/L epinephrine did aggregate the cells. Arachidonate-induced aggregation appeared to be a toxic phenomenon: the ED50 for aggregation was statistically indistinguishable from that for cytotoxicity, and aspirin only mildly blunted the response. In contrast, epinephrine-induced aggregation was not associated with lactic dehydrogenase release or the loss of trypan blue exclusion and was blunted by propranolol; radiopindolol-binding studies confirmed the presence of a beta-adrenergic receptor. There were approximately 3,000 receptors/cell, with no statistically significant difference between normal and chronic lymphocytic leukemia B cells or between B cells and T cells (separated by rosetting techniques). The Kd for the B cells' receptor, however, was less than that for T cells by a factor of ten (P less than .01). We conclude that B cells may aggregate when stimulated and that they--like T cells--have beta-adrenergic receptors. Adrenergically mediated changes in B cell adhesiveness may play a role in regulating lymphocyte traffic; in the rare patient with truly enormous B cell counts, we postulate that they may be an occasional cause of morbidity.

journal_name

Blood

journal_title

Blood

authors

Hammerschmidt DE,Jeanneret C,Husak M,Lobell M,Jacob HS

subject

Has Abstract

pub_date

1988-05-01 00:00:00

pages

1470-4

issue

5

eissn

0006-4971

issn

1528-0020

journal_volume

71

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia.

    abstract::By using a cDNA clone of the myeloperoxidase (MPO) gene, we have studied, by Northern blot analysis, the level of MPO mRNA in eight cases of acute lymphoblastic leukemia (ALL). The blast cell populations studied were characterized by morphologic, cytochemical, immunochemical, and molecular criteria. With all the metho...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ferrari S,Mariano MT,Tagliafico E,Sarti M,Ceccherelli G,Selleri L,Merli F,Narni F,Donelli A,Torelli G

    更新日期:1988-09-01 00:00:00

  • Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment?

    abstract::Notch signaling pathway regulates many different events of embryonic and adult development; among them, Notch plays an essential role in the onset of hematopoietic stem cells and influences multiple maturation steps of developing lymphoid and myeloid cells. Deregulation of Notch signaling determines several human diso...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-08-376061

    authors: Nwabo Kamdje AH,Krampera M

    更新日期:2011-12-15 00:00:00

  • Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis.

    abstract::Maintenance of myeloid cell homeostasis requires continuous turnover of phagocytes from the bloodstream, yet whether environmental signals influence phagocyte longevity in the absence of inflammation remains unknown. Here, we show that the gut microbiota regulates the steady-state cellular lifespan of neutrophils and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-10-675173

    authors: Hergott CB,Roche AM,Tamashiro E,Clarke TB,Bailey AG,Laughlin A,Bushman FD,Weiser JN

    更新日期:2016-05-19 00:00:00

  • Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels.

    abstract::The t(11;14)(q13;q32) is the most common translocation in multiple myeloma (MM), resulting in up-regulation of cyclin D1. We used a segregation fluorescence in situ hybridization (FISH) assay to detect t(11;14) breakpoints in primary MM cases and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) to qu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-11-3837

    authors: Specht K,Haralambieva E,Bink K,Kremer M,Mandl-Weber S,Koch I,Tomer R,Hofler H,Schuuring E,Kluin PM,Fend F,Quintanilla-Martinez L

    更新日期:2004-08-15 00:00:00

  • Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment.

    abstract::The pathophysiology of microthrombocytopenia in the Wiskott-Aldrich syndrome (WAS) and its milder form, X-linked thrombocytopenia (XLT), is unclear. Although quantitative defects are correctable by splenectomy, residual platelet abnormalities are suggestive of intrinsic disturbances of production. In contrast to human...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-03-1219

    authors: Sabri S,Foudi A,Boukour S,Franc B,Charrier S,Jandrot-Perrus M,Farndale RW,Jalil A,Blundell MP,Cramer EM,Louache F,Debili N,Thrasher AJ,Vainchenker W

    更新日期:2006-07-01 00:00:00

  • Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment.

    abstract::We report 2 new mutations identified in 3 patients and characterized by the markedly decreased affinity of von Willebrand factor (vWF) for factor VIII (FVIII). Patients 2 and 3, who have a typical type 2N phenotype, were found to be compound heterozygous for Arg91Gln and Cys25Tyr or Cys95Phe, respectively. Patient 1, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jorieux S,Fressinaud E,Goudemand J,Gaucher C,Meyer D,Mazurier C

    更新日期:2000-05-15 00:00:00

  • Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.

    abstract::The human erythrocyte blood group system Cromer consists of high-incidence and low-incidence antigens that reside on decay-accelerating factor (DAF; CD55), a glycosyl-phosphatidylinositol-anchored membrane protein that regulates complement activation on cell surfaces. In the Cromer phenotypes Dr(a-) and Inab there is ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lublin DM,Mallinson G,Poole J,Reid ME,Thompson ES,Ferdman BR,Telen MJ,Anstee DJ,Tanner MJ

    更新日期:1994-08-15 00:00:00

  • Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.

    abstract::Induction of red blood cell (RBC) fetal hemoglobin (HbF; α2γ2) ameliorates the pathophysiology of sickle cell disease (SCD) by reducing the concentration of sickle hemoglobin (HbS; α2βS2) to inhibit its polymerization. Hydroxyurea (HU), the only US Food and Drug Administration (FDA)-approved drug for SCD, acts in part...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-11-814335

    authors: Zhang Y,Paikari A,Sumazin P,Ginter Summarell CC,Crosby JR,Boerwinkle E,Weiss MJ,Sheehan VA

    更新日期:2018-07-19 00:00:00

  • AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice.

    abstract::Emerging successful clinical data on gene therapy using adeno-associated viral (AAV) vector for hemophilia B (HB) showed that the risk of cellular immune response to vector capsid is clearly dose dependent. To decrease the vector dose, we explored AAV-8 (1-3 × 10(12) vg/kg) encoding a hyperfunctional factor IX (FIX-Pa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-588194

    authors: Crudele JM,Finn JD,Siner JI,Martin NB,Niemeyer GP,Zhou S,Mingozzi F,Lothrop CD Jr,Arruda VR

    更新日期:2015-03-05 00:00:00

  • Heme induces rapid endothelial barrier dysfunction via the MKK3/p38MAPK axis.

    abstract::Several studies demonstrate that hemolysis and free heme in circulation cause endothelial barrier dysfunction and are associated with severe pathological conditions such as acute respiratory distress syndrome, acute chest syndrome, and sepsis. However, the precise molecular mechanisms involved in the pathology of heme...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003986

    authors: James J,Srivastava A,Varghese MV,Eccles CA,Zemskova M,Rafikova O,Rafikov R

    更新日期:2020-08-06 00:00:00

  • HIV gene therapy research advances.

    abstract::In this issue of Blood, Tebas et al report antiviral effects in a clinical trial of multiple infusions of lentiviral vector–modified autologous CD4T lymphocytes in 17 HIV-infected patients aviremic on antiretroviral therapy (ART). ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2013-01-475921

    authors: Jacobson JM

    更新日期:2013-02-28 00:00:00

  • Hemoglobin Great Lakes (beta 68 [E12] leucine replaced by histidine): a new high-affinity hemoglobin.

    abstract::Hemoglobin Great Lakes, beta 68 (E12) Leu replaced by His is a new high oxygen affinity hemoglobin variant discovered in a 29-yr-old female having numerous hospitalizations for thrombophlebitis associated with mild erythrocytosis. The mutant hemoglobin has normal stability and normal electrophoretic mobility, but incr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rahbar S,Winkler K,Louis J,Rea C,Blume K,Beutler E

    更新日期:1981-10-01 00:00:00

  • Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells.

    abstract::Interferons (IFNs) initiate their effects by interacting with specific high-affinity cell surface receptors, but little is known about the physiology of IFN receptor interaction in vivo. Treatment of patients suffering from hairy cell leukemia (HCL) with human recombinant alpha IFN results in significant tumor regress...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Billard C,Sigaux F,Castaigne S,Valensi F,Flandrin G,Degos L,Falcoff E,Aguet M

    更新日期:1986-03-01 00:00:00

  • Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas.

    abstract::Chimeric antigen receptor (CAR) T cells have emerged as a novel form of treatment of patients with B-cell malignancies. In particular, anti-CD19 CAR T-cell therapy has effected impressive clinical responses in B-cell acute lymphoblastic leukemia and diffuse large B-cell lymphoma. However, not all patients respond, and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-04-842708

    authors: Scarfò I,Ormhøj M,Frigault MJ,Castano AP,Lorrey S,Bouffard AA,van Scoyk A,Rodig SJ,Shay AJ,Aster JC,Preffer FI,Weinstock DM,Maus MV

    更新日期:2018-10-04 00:00:00

  • Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction.

    abstract::The bcr-abl translocation characteristic of chronic myeloid leukemia (CML) was detected by the polymerase chain reaction (PCR) modified to use mRNA as the starting material. Amplification of a sequence spanning the bcr-abl junction was obtained by using peripheral blood cells from all of 20 patients with classic CML, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dobrovic A,Trainor KJ,Morley AA

    更新日期:1988-12-01 00:00:00

  • Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions.

    abstract::The effectiveness of arabinosylcytosine (ara-C) for the treatment of acute myelogenous leukemia (AML) depends on the formation of its active metabolite, the triphosphate of ara-C (ara-CTP). Using biochemical modulation strategies to increase the accumulation of ara-CTP in leukemia blasts, a clinical protocol was desig...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Gandhi V,Estey E,Keating MJ,Chucrallah A,Plunkett W

    更新日期:1996-01-01 00:00:00

  • Thrombosis in primary myelofibrosis: incidence and risk factors.

    abstract::We assessed frequency and predictive factors for major cardiovascular (CV) events in 707 patients with primary myelofibrosis (PMF) followed in 4 European institutions. A total of 236 deaths (33%) were recorded for an overall mortality of 7.7% patient-years (pt-yr). Fatal and nonfatal thromboses were registered in 51 (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-08-238956

    authors: Barbui T,Carobbio A,Cervantes F,Vannucchi AM,Guglielmelli P,Antonioli E,Alvarez-Larrán A,Rambaldi A,Finazzi G,Barosi G

    更新日期:2010-01-28 00:00:00

  • An epitope of the transferrin receptor is exposed on the cell surface of high-grade but not low-grade human lymphomas.

    abstract::In attempting to identify antigens that are differentially expressed on tumor cells following transformation from follicular small cleaved cell lymphoma (FSC) to immunoblastic lymphoma (IL), we identified a unique epitope of the transferrin receptor (TfR). The epitope is available for binding in aggressive lymphomas b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Esserman L,Takahashi S,Rojas V,Warnke R,Levy R

    更新日期:1989-12-01 00:00:00

  • Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized tria

    abstract::From 1990 to 1996, a total of 386 adult patients with early/intermediate Hodgkin disease (HD) were randomly assigned to receive 3 cycles of adriamycin, bleomycin, vinblastine, dacarbazine (an alkylating agent), and methylprednisolone (ABVDm, arm A) or epirubicin, bleomycin, vinblastine, methotrexate, and methylprednis...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2003-05-1611

    authors: le Maignan C,Desablens B,Delwail V,Dib M,Berthou C,Vigier M,Ghandour C,Atmani S,Casassus P,Maisonneuve H,Le Mevel A,Traulle C,Bernard M,Briere J,Colonna P,Andrieu JM

    更新日期:2004-01-01 00:00:00

  • Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma.

    abstract::We evaluated a treatment strategy targeting both lymphoma cells (by rituximab) and the microenvironment (by thalidomide) in 16 patients with relapsed/refractory mantle cell lymphoma (MCL). Rituximab was administered at 375 mg/m(2) for 4 weekly doses concomitantly with thalidomide (200 mg daily, with a dose increment t...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2004-03-1091

    authors: Kaufmann H,Raderer M,Wöhrer S,Püspök A,Bankier A,Zielinski C,Chott A,Drach J

    更新日期:2004-10-15 00:00:00

  • Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.

    abstract::Techniques for the quantitation of virus-specific and alloantigen-reactive T cells vary in their measurement of clinically relevant T-cell effector populations, their sensitivity and quantitative accuracy, and the time required to obtain measurable results. We compared frequencies of Epstein-Barr virus (EBV)-specific ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.5.1730

    authors: Koehne G,Smith KM,Ferguson TL,Williams RY,Heller G,Pamer EG,Dupont B,O'Reilly RJ

    更新日期:2002-03-01 00:00:00

  • Virus-cell interactions in a natural killer-like cell line from a patient with lymphoblastic lymphoma.

    abstract::Lymphoproliferative disorders involving Epstein-Barr virus (EBV) infected natural killer (NK) cells are reported with increasing frequency, but the nature and role of EBV infection in these cells remains undefined. In this study, we have investigated virus-cell interactions in the EBV-positive YTN10 cell line, an NK-l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kanegane H,Wang F,Tosato G

    更新日期:1996-12-15 00:00:00

  • Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?

    abstract::Despite many studies on the pathophysiology of antiphospholipid antibodies (aPL), the mechanism by which aPL causes thrombosis has not been established. We have tried to elucidate the paradox between the prolongation of the clotting time of phospholipid-dependent coagulation tests in vitro and the occurrence of thromb...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Oosting JD,Derksen RH,Bobbink IW,Hackeng TM,Bouma BN,de Groot PG

    更新日期:1993-05-15 00:00:00

  • T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage.

    abstract::The family of core-binding factors includes the DNA-binding subunits Runx1-3 and their common non-DNA-binding partner CBFbeta. We examined the collective role of core-binding factors in hematopoiesis with a hypomorphic Cbfb allelic series. Reducing CBFbeta levels by 3- or 6-fold caused abnormalities in bone developmen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-021188

    authors: Talebian L,Li Z,Guo Y,Gaudet J,Speck ME,Sugiyama D,Kaur P,Pear WS,Maillard I,Speck NA

    更新日期:2007-01-01 00:00:00

  • Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.

    abstract::Rituximab, a monoclonal antibody that targets CD20 on B cells, is now central to the treatment of a variety of malignant and autoimmune disorders. Despite this success, a substantial proportion of B-cell lymphomas are unresponsive or develop resistance, hence more potent anti-CD20 monoclonal antibodies (mAbs) are cont...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-263533

    authors: Beers SA,French RR,Chan HT,Lim SH,Jarrett TC,Vidal RM,Wijayaweera SS,Dixon SV,Kim H,Cox KL,Kerr JP,Johnston DA,Johnson PW,Verbeek JS,Glennie MJ,Cragg MS

    更新日期:2010-06-24 00:00:00

  • Tumor vascular targeting therapy with viral vectors.

    abstract::Tumor angiogenesis is crucial for the progression and metastasis of cancer. The vasculature of tumor tissue is different from normal vasculature. Therefore, tumor vascular targeting therapy could represent an effective therapeutic strategy with which to suppress both primary tumor growth and tumor metastasis. The use ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2005-10-4114

    authors: Liu Y,Deisseroth A

    更新日期:2006-04-15 00:00:00

  • A case of mistaken identity.

    abstract::McCullough and colleagues show that problems with cord banking still exist. To improve the results of cord transplantations, more attention should be given to ensuring quality standards rather than just collecting more units. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2009-06-226738

    authors: Querol S

    更新日期:2009-08-20 00:00:00

  • Stimulation of persisting colonies in agar cultures by sera from patients with CML and AML.

    abstract::Cord plasma contains colony-stimulating activity (CSA) which stimulates the in vitro clonal growth of neutrophils, eosinophils, macrophages, erythrocytes, and persisting mast cells in semisolid cultures. Analysis of day 35 colonies in agar cultures was found to be a suitable means of demonstrating this activity and di...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Brown RD,Yuen E,Kronenberg H,Rickard KA

    更新日期:1986-07-01 00:00:00

  • How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage).

    abstract::Indolent systemic mastocytosis (SM) patients have a varied clinical presentation, ranging from predominantly cutaneous symptoms to recurrent systemic symptoms (eg, flushing, palpitations, dyspepsia, diarrhea, bone pain) that can be severe and potentially life threatening (anaphylaxis). Mastocytosis patients without sk...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-453183

    authors: Pardanani A

    更新日期:2013-04-18 00:00:00

  • Binding of recombinant interleukin-1 beta to the third complement component and alpha 2-macroglobulin after activation of serum by immune complexes.

    abstract::Activation of human normal serum with tetanus/antitetanus immune complexes (TAT-IC) resulted in increased binding of 125I-labeled interleukin-1 beta (IL-1 beta) to serum factors, as opposed to untreated serum. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by autoradiography showed label...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Borth W,Urbanski A,Prohaska R,Susanj M,Luger TA

    更新日期:1990-06-15 00:00:00